Viewing nowCombinationSitagliptin and Metformin Extended-Release Tablet 50/500 mg
Sitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Dongkook Pharmaceutical Co., Ltd.

MFDS item code 202201962 · Approved 2022.05.11 · Insurance code 653405230
Improvement of glycemic control in patients with type 2 diabetes
This medication helps patients with type 2 diabetes achieve better blood sugar control in conjunction with dietary and exercise therapies. The combination of sitagliptin and metformin improves blood glucose levels to help maintain health. Therefore, it is used for improving blood sugar management.
The dose of this medication for antidiabetic therapy should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: sitagliptin 100 mg and metformin 2000 mg. To reduce gastrointestinal adverse reactions caused by metformin, this medication should be taken with a meal once daily, preferably in the evening, and the dose should be increased gradually. To maintain its extended-release properties, this medication must be swallowed whole without splitting, crushing, grinding, or chewing. Take 1 tablet of this medication 100/1000 mg extended-release tablet once daily. Patients taking this medication 50/500 mg extended-release tablet or 50/1000 mg extended-release tablet should take 2 tablets together once daily. 1. Patients not currently receiving metformin: For patients with no prior experience of antidiabetic drug treatment who have difficulty achieving adequate glycemic control with monotherapy, or for whom adequate glycemic control cannot be achieved with sitagliptin monotherapy, the initial total daily dose of this medication is sitagliptin 100 mg and metformin 1000 mg. If adequate glycemic control cannot be achieved with the initial dose, the dose may be increased gradually up to the maximum recommended daily dose of metformin, 2000 mg, to reduce gastrointestinal adverse reactions caused by metformin. 2. Patients receiving metformin: - The recommended initial total daily dose of this medication for patients who cannot achieve adequate glycemic control with metformin monotherapy is sitagliptin 100 mg and their current dose of metformin. - Patients switching to this medication from concomitant sitagliptin and metformin therapy may start at their current doses of sitagliptin and metformin. - Patients taking immediate-release metformin at a current dose of 850 mg or 1000 mg twice daily may start with 2 tablets of this medication 50/1000 mg extended-release tablet once daily. 3. Patients unable to achieve adequate glycemic control with combination therapy of metformin and a sulfonylurea, metformin and insulin, or metformin and a thiazolidinedione: The initial total daily dose of this medication is sitagliptin 100 mg, and the initial dose of metformin should be determined based on the patient's blood glucose level and current dose. Increase the dose gradually to reduce gastrointestinal adverse reactions caused by metformin. When administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin. Patients with renal impairment This medication may be used, with the following dosage adjustment, in patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] ≥ 45 and <60 mL/min or estimated glomerular filtration rate (eGFR) ≥ 45 and <60 mL/min/1.73m2), who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin is 500 mg or 850 mg once daily, treatment should not be initiated with this medication. The maximum recommended dose of metformin is 1000 mg daily. Renal function should be carefully monitored every 3-6 months. If renal function declines to CrCl <45 mL/min or eGFR <45 mL/min/1.73m2, this medication must be discontinued immediately.
This medication contains both sitagliptin and metformin and is primarily used for blood sugar control in patients with type 2 diabetes. While taking this medication, serious allergic reactions may occur; if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck appear, discontinue use immediately and consult a doctor. Serious side effects including pancreatitis (inflammation of the pancreas) have been reported, so if symptoms such as abdominal pain, nausea, vomiting, or loss of appetite occur, notify healthcare personnel immediately. Metformin is known to rarely cause a life-threatening metabolic disorder called lactic acidosis, thus, this medication should not be taken in cases of severe dehydration, heart disease, or acute infections. Patients with moderate or severe renal impairment, those with acute heart failure or sepsis, and women who are pregnant or breastfeeding should not take this medication. This medication poses a risk of hypoglycemia, so caution should be exercised if meals are skipped, irregular eating habits occur, or excessive exercise is performed. Particularly when taken with insulin or sulfonylurea drugs, special attention should be paid to hypoglycemic symptoms. Gastrointestinal side effects such as diarrhea, nausea, and abdominal pain may occur, so consult a doctor if symptoms are severe. Regular monitoring of kidney function and blood tests to check liver and kidney status is important while taking this medication, and vitamin B12 levels should also be monitored periodically. Excessive alcohol consumption may increase the risk of lactic acidosis, so alcohol should be avoided during treatment. If undergoing surgery or tests requiring contrast agents, this medication should be temporarily discontinued before and after the tests, and resumed only after kidney function has returned to normal. Elderly patients may be at higher risk of decreased kidney function, thus, dose adjustments and regular monitoring are necessary. If overdose is suspected, visit a hospital immediately to receive appropriate treatment, as this medication can be partially removed by hemodialysis. While taking this medication, it is important to regularly check blood sugar levels and carefully monitor the effects and side effects of the medication.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to prevent exposure to air and moisture. Additionally, it is best to keep the medication at room temperature between 1°C and 30°C, avoiding extremes of heat or cold.
Light blue, oval-shaped, bilayered extended-release film-coated tablet
28 tablets/bottle, 56 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Dongkook Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Korea Hutech Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.